Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.



Trametinib: A Possible New Treatment for Severe Kaposiform Lymphangiomatosis

The lymphatic system, part of the immune system, is made up of vessels that help to protect the body from infection and foreign substances. It produces and releases lymphocytes (white blood cells) and other immune cells that monitor and then destroy pathogens — such as bacteria, viruses, parasites, and fungi — whenever they enter your […]
Read More
Airway Clearance System

New Hope for Lung Disease Patients: Ayelet’s Story

Synchrony Medical’s LibAirty, developed in collaboration with Sheba pulmonologists, is an airway clearance system in clinical development designed to enable patients with chronic lung disease to receive high-quality respiratory therapy in the privacy of their homes. Recently, LibAirty helped save the life of Ayelet, a 38-year-old cystic fibrosis patient who traveled from Israel to the […]
Read More

Sheba Ranked Among the World’s Best Hospitals for the Fifth Consecutive Year

Following Sheba’s inclusion in Newsweek’s 2023 list of the world’s best smart hospitals, as well as best cardiology, neurosurgery, and gastroenterology hospital rankings, we are proud to share that, for the fifth year in a row, Sheba was named by Newsweek and Statista as one the best hospitals in the world, alongside renowned medical institutions […]
Read More
Non-Hodgkin's Lymphoma

Overcoming Non-Hodgkin’s Lymphoma: Marina’s Story

Marina’s story started a year before her diagnosis. She began feeling tired and apathetic, but blood tests indicated nothing was wrong. When symptoms worsened, her doctor suggested taking blood tests every week to monitor changes over time. After undergoing a few tests, she was referred to an ultrasound, which revealed that she was suffering from […]
Read More
COVID-19 Booster Shot

Optimizing COVID-19 Booster Shot Usage: A New Sheba Study

A new Sheba study involving first-generation Pfizer COVID-19 vaccines, published in the New England Journal of Medicine, showed that the fourth vaccine dose increased antibody levels for only around 13 weeks.  Conducted by Sheba researchers alongside experts from the Israeli Health Ministry and Columbia University researchers, the study comprised over 6,000 Sheba employees and volunteers. […]
Read More
Breast Cancer

Anna’s Story of Hope and Healing

Originally from Siberia, Russia, Anna was living with her husband and their now 13-year-old son in Madagascar, where her husband works. She loves sports and frequently goes to the gym. When Anna’s brother was diagnosed with advanced cancer, they immediately returned to Russia, as she wanted to be close to him. Anna remained by his […]
Read More
Australia-Israel Innovation Summit

The 3rd Annual Australia-Israel Innovation Summit

In recent months, more than 700 people attended the hybrid 2022 Australia-Israel Innovation Summit to discuss the future of cyber security, digital health, and climate tech. The event, themed ‘The World In Transition,’ was hosted by the Australia-Israel Chamber of Commerce (AICC) in partnership with the Embassy of Israel and the Israel Trade Commission. It […]
Read More
Igor’s Story

Fighting for a Future: Igor’s Story of Hope and Determination

Igor’s mother recalls the birth of her son as a challenging experience. He was hospitalized for about a month following respiratory failure requiring resuscitation. Fortunately, Igor grew up normally. “He is a wonderful boy, loves to play with animals and cars, and is very energetic,” describes his mother, Alina.  However, upon graduating 1st grade in […]
Read More
Sheba and Peter Mac

Sheba Joins Peter Mac for a New Prostate Cancer Treatment Trial

The POPSTAR II clinical trial, due to begin in early 2023 at multiple sites, will compare two cutting-edge treatments for men with advanced prostate cancer – lutetium PSMA (LuPSMA) therapy and stereotactic ablative radiotherapy (SABR). During a recent visit to Australia, Sheba’s Director General, Prof. Yitshak Kreiss, signed a letter of intent making Sheba an […]
Read More